TMCnet News
GOHG, MFLI, ALRX, OPSY, ISR, ZVTK, August 18 Daily Market Movers Digest Report from OTCPicks.com(M2 PressWIRE Via Acquire Media NewsEdge) Our Stocks to Watch today include Global Holdings Inc. (OTCBB: GOHG), Muscle Flex Inc. (OTC: MFLI), AlphaRx Inc. (OTCBB: ALRX), Optical Systems Inc. (OTC: OPSY), IsoRay Inc. (Amex: ISR) and Zevotek Inc. (OTC: ZVTK). Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts. ALPHA 1 SECURITY INCORPORATED (OTCBB: GOHG) "Up 8.33% in morning trading" Detailed Quote: http://www.otcpicks.com/quotes/GOHG.php Company Profile: http://www.otcpicks.com/global-holdings/global-holdings.htm Alpha1 provides Internet based (IP) data security services as well as develops and markets software and microprocessor-based products. Alpha1's primary data security products use an advanced form of computer security technology referred to as public key infrastructure (PKI) which enables Alpha1's products to integrate. Alpha1 is an approved NSA C-2 classified contractor. GOHG News: August 18 - Alpha1 Security Announces New $14 Million Submitted Bid to the Department of Defense Alpha1 Security announces a bid valued at up to $14mm to the Department of Defense to provide secure wireless communications, services and hardware to each division within the Department. As previously announced Alpha1 Security Inc. has entered into an acquisition agreement with Global Holdings, Inc. (OTCBB: GOHG). The services Alpha1 Security provides would be based on our patent-protected technology that Alpha1 Security owns. The technology revolutionizes the way in which enterprises connect wireless networks securely. "Alpha1 Security is the technology leader of secure wireless networking technology -- our technology has been reviewed and endorsed by the government. We are the leader in security technology that has been reviewed and endorsed by the National Security Agency and is C2 certified," says Mark McCloy, COO and President, Alpha1 Security Inc. Alpha1 Security is the technology leader in the $20BB market for providing secure network solutions and services. Alpha1 provides Internet based (IP) data security services as well as develops and markets software and microprocessor-based products. Alpha1's primary data security products use an advanced form of computer security technology referred to as public key infrastructure (PKI) which enables Alpha1's products to integrate. Alpha1 is an approved NSA C-2 classified contractor. MUSCLE FLEX INCORPORATED (OTC: MFLI) Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast. MFLI News: August 18 - Muscle Flex Inc. to Work With Danny Sarnoff, Grandson of David Sarnoff One of Time Magazine's 20 Builders and Titans, in Directing and Producing The BUDDY Tablet Caddy North American Infomercial Muscle Flex Inc. (OTC: MFLI) announced that Danny Sarnoff, the Grandson of David Sarnoff, will direct and produce The BUDDY Tablet Caddy North American infomercial. Mr. Sarnoff possesses a wealth of directing, film and television experience and comes from a rich and distinguished family heritage of television and broadcasting. He is the Grandson of David Sarnoff who is known as the "father of broadcasting" and was the founder of the National Broadcasting Corporation (NBC) as well as the Chairman and CEO of Radio Corporation of America (RCA) from 1947 till 1971. David Sarnoff is one of Time 100's Builders and Titans who are Time Magazine's twenty innovators who changed "how the world works." As well, Mr. Sarnoff's father, Thomas Sarnoff, was the Executive Vice President, West Coast, of the National Broadcasting Company, Inc., as well as President of NBC Entertainment Corporation and his Uncle, Robert Sarnoff, also became the Chairman and CEO of RCA and NBC. Danny Sarnoff's list of accomplishments is extensive. He was CEO of Pioneer Pictures and produced many made-for-television-movies including the new "Bonanza" and the "Star Trek" Specials. In the early 80s, Mr. Sarnoff began his career as an NBC executive and a member of the RCA new business task force. He developed and was CEO of Gamebay.com, one of the first of a new breed of profile-driven internet marketing companies which was sold to Multimedia Games, Inc. in April of 2001. Between 1993 and 1998, Mr. Sarnoff was a member of the Board of Directors and Vice President of Multimedia Games, Inc. with responsibility for designing and developing interactive high-speed bingo and video lottery games. Today, his company represents the bulk of the transactional database systems and progressive jackpot games which have become the core of the Native American Indian Gaming industry. In September 1998, he became President of TV Games, Inc; a subsidiary of Multimedia Games engaged in developing TV Game shows. Of late, Mr. Sarnoff has spent much time in the infomercial space directing, producing and writing for a number of "As Seen on TV" projects. Muscle Flex Inc. and Mr. Sarnoff came to a decidedly like-minded decision to work together to direct and produce The BUDDY Tablet Caddy infomercial. Muscle Flex is excited to have the opportunity to work with the caliber of individual such as Mr. Sarnoff for two reasons; he provides an intense television background with an unconventional approach to infomercial development and secondly, from the onset, Muscle Flex Inc. CEO, Danny Alex and Mr. Sarnoff were synergistic in their business approach and vision and discussed an expanded working relationship to yield the potential for additional opportunities that may exist between Muscle Flex Inc. and Mr. Sarnoff going forward as the relationship and projects develop. "Innovation in the infomercial idiom is very important to Muscle Flex Inc.," commented Danny Alex, CEO of Muscle Flex Inc. "We have no desire to do what has been done but rather we want to break new ground in defining 'As Seen on TV' media. From our first meeting, Mr. Sarnoff and I had an amazing affinity with concepts and macro strategy and with that came the potential for a number of other projects and a long reaching relationship past The BUDDY Tablet Caddy infomercial. Danny Sarnoff brings a new and fresh approach to Muscle Flex Inc.'s 'As Seen on TV' direct response infomercials and more importantly, he understands the approach we are taking with Muscle Flex. We are a 'people' orientated company and we need our customers to know that passion is the guiding principle behind what we do on TV and our products. Mr. Sarnoff's desire to work with Muscle Flex Inc. validates our business plan and our method of execution." Danny Sarnoff provides Muscle Flex Inc. with a wealth of industry experience and relationships that firmly places Muscle Flex Inc. in an advantageous position to further its media presence in Los Angeles and abroad. Muscle Flex Inc. and Mr. Sarnoff have begun formulating the final BUDDY tablet Caddy infomercial script as well as implementing the final stages of the video shoot which is expected to be shot in Los Angeles imminently. ALPHARX INCORPORATED (OTCBB: ALRX) Detailed Quote: http://www.otcpicks.com/quotes/ALRX.php Company Profile: http://www.otcpicks.com/alpharx/alpharx.htm AlphaRx is a specialty pharmaceutical company dedicated to developing proven therapies by reformulating FDA approved and marketed drugs which through the application of its proprietary site-specific nano drug delivery technology, offers improved medical benefits and a potential for significant commercial product development. ALRX News: August 17 - AlphaRx Completes Lyophilization Process for Zysolin AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, announced that it has completed the lyophilization process for Zysolin, allowing the company to proceed to clinical batch material manufacturing for human trials. This process has been solely developed by AlphaRx's scientists and the resulting formulations have been successfully tested in animal studies conducted by the U.S. Army under a Material Transfer Agreement. "This is a technological milestone for AlphaRx and the entire nanomedicine industry," commented Dr. Joseph Schwarz, AlphaRx's Chief Scientist. "It is well known that many FDA approved ingredients used in nanomedicine formulations can not be readily lyophilized, representing the major obstacle to their therapeutic development, a critical step which we have overcome." Many biotechnology products require lyophilization, a process of freeze-drying sterile solutions to permit a shelf stable dosage form. By removing the water from the material and sealing the material in a vial, it can be easily stored, shipped, and later reconstituted to its original form for administration. Zysolin is protected by 3 U.S. patents pending and the Company plans to file a new patent application to protect this new process. ABOUT ZYSOLIN Zysolin is a Tobramycin compound, encapsulated in AlphaRx's Nano Drug Delivery Platform, intended for the adjunctive treatment of Gram-negative pneumonia in intubated and mechanically-ventilated patients. Zysolin improves the intracellular activity of Tobramycin - in layman's term, increasing the drug concentration of Tobramycin inside human macrophages, thus improving its antibacterial activity against intracellular Klebsiella, Pseudomondas aeruginosa and Staphylococcus bacterial strains in pneumonia patients. The active ingredient in Zysolin, Tobramycin, has a long-standing and proven clinical treatment record. Delivered by inhalation, using proprietary nanotechnology developed by AlphaRx, the company believes Zysolin will have an attractive safety, tolerability and efficacy profile when compared to injectible Tobramycin. OPTICAL SYSTEMS INCORPORATED (OTC: OPSY) Detailed Quote: http://www.otcpicks.com/quotes/OPSY.php Company Profile: http://www.otcpicks.com/optical-systems/optical-systems.htm Optical Systems, Inc., through its operating subsidiary, Automotive Software Designers, Inc., develops technology and services for the automotive retail industry designed to maximize productivity and increase profits at auto dealerships. ASDI's flagship technology solution, Save-a-Deal, is a turnkey customer relationship management (CRM) tool for auto dealerships. Our business development center (BDC) provides a variety of services designed to help auto dealerships drive traffic to their showroom or Web site, retain customers and generate new streams of revenue. OPSY News: August 17 - Optical Systems, Inc. Hires Independent Auditors, Plans on Becoming a Fully Reporting Company Optical Systems, Inc. (OTC: OPSY), a leading provider of software and services to the automotive retail industry, announced that the company has hired Gruber & Company, LLC to act as an independent auditor to the company, and to audit its financials for 2007 and 2008. "Moving off of the pink sheets exchange and on to a higher, more recognized exchange is a top priority," said B.J. Grisaffi, Chairman and CEO of Optical Systems, Inc. "The audited financial information should allow us to create more visibility for our company, and more value for our shareholders." The hiring of the firm coincides with Optical Systems' plans to become a fully reporting company and to list its shares for trading on the Over the Counter Bulletin Board. Gruber & Company, LLC also provides a wide-range of advisory services on business subjects including: public and private mergers and acquisitions, due diligence, SOX policy design; internal controls procedures and systems, identifying financial risk and exposure; restructuring plans; and profitability studies. "The listing of our stock on Over the Counter Bulletin Board represents the first of several building blocks to position Optical Systems for future growth," said Grisaffi. ISORAY INCORPORATED (AMEX: ISR) "Up 109.80% in morning trading" Detailed Quote: http://www.otcpicks.com/quotes/ISR.php IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed. The Cesium-131 seed offers a significantly shorter radiation half-life than the two other isotopes commonly used for brachytherapy, which results in a substantially faster delivery of therapeutic radiation, a theoretically improved radiation delivery against aggressively replicating cancer, and the potential for a reduced longevity of common brachytherapy side effects. Cesium-131 is currently used in the treatment or prostate cancer and ocular melanoma, among other cancerous conditions. IsoRay is based in Richland, Washington. ISR News: August 18 - IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors IsoRay, Inc. (Amex: ISR) announced that it has received clearance from the FDA for its Premarket Notification, [510(k)] for Proxcelan Cesium-131 Brachytherapy Seeds enabling the company to preload Cesium-131 into flexible braided strands and surgical mesh. This FDA clearance allows IsoRay to market Cesium-131 seeds for use in the treatment of cancers well beyond the current prostate market. This order clears the product for commercial distribution for treatment of lung and head and neck tumors as well as tumors in other organs. While Cesium-131 seeds themselves have been cleared for this indication since 2003, this current 510(k) allows Cesium-131 to be delivered in a new, convenient and sterile format that can be implanted without additional seed loading by the facility. The 510(k) also clears the application of the braided strands onto a bioabsorbable mesh matrix to further facilitate implant procedures. Dwight Babcock, IsoRay CEO, stated. "The FDA's decision will accelerate our strategy to significantly broaden the scope of Cesium-131 cancer treatments well beyond the current major prostate market. A growing number of physicians have indicated that they believe Cs-131's unique characteristics of shorter half life and high energy are particularly suitable for many applications beyond prostate." In 2008 it was estimated that there were a total of 47,560 head and neck cases and 220,000 cases of lung cancer diagnosed in the United States. (Cancer Management: A Multidisciplinary Approach, 11th Edition (2008). Richard Pazdur, Lawrence R. Coia, William J. Hoskins, Lawrence D. Wagman; American Cancer Society, 2009.) ZEVOTEK INC. (OTC: ZVTK) "Up 45.00% in morning trading" Detailed Quote: http://www.otcpicks.com/quotes/ZVTK.php Zevotek, Inc. plans to market and sell independently a range of distinct and independent lines of home care and household products. In May 2007, the company entered into a license agreement to sell an energy saving compact fluorescent light bulb named the Ionic Bulb. The company plans to market the Ionic Bulb through TV infomercials, catalogs, magazines and major U.S. retail and specialty stores. ZVTK News: August 18 - Zevotek to Consider Branding the Ionic Bulb Zevotek, Inc. (OTC: ZVTK) has begun preliminary discussions on a branding of its ionic bulb product. In order to gain the largest possible foothold into this U.S. and global electronics market, we are considering a future partnership with a major electronic consumer good producer. If such a partnership agreement can be reached the bulb would be re-branded to reflect the new collaboration. We are only in the early stages of negotiating such a possibility, but there has been interest shown by a major electronic consumer goods producer. ABOUT OTCPICKS.COM OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at [email protected]. Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever. Release of Liability: Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has been compensated twenty thousand free trading shares by a non-controlling third party for GOHG advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars from Dana Alex for MFLI advertising and promotional services. OTCPicks.com has been compensated seven thousand five hundred dollars by a third party (Blue Wave Advisors) for ALRX advertising and promotional services. OTCPicks.com has been compensated one hundred thousand free trading shares by a third party for OPSY advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure-details.htm. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled. The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results. Third Party Web Sites and Information: OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS |